Aktis Oncology, Inc. AKTS
15.70 USD -0.12 (-0.76%)
Nov 9, 2026, 10:21 AM EST
15.36 Day range 16.16
13.96 52-week range 34.19
- YTD
- -29.91%
- 1 year
- -29.91%
News
benzinga.com Wedbush Reiterates Outperform on Aktis Oncology, Maintains $35 Price Target Wedbush analyst David Nierengarten reiterates Aktis Oncology (NASDAQ:AKTS) with a Outperform and maintains $35 price target.
benzinga.com Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519 Phase 1b BActinium-2 clinical trial is evaluating AKY-2519 in patients with non-small cell lung cancer (NSCLC) and other B7-H3 expressing tumorsEnrollment is ongoing in the Phase 1b BActinium-1…- benzinga.com Oppenheimer Initiates Coverage On Aktis Oncology with Outperform Rating, Announces Price Target of $40 Oppenheimer analyst Jeff Jones initiates coverage on Aktis Oncology (NASDAQ:AKTS) with a Outperform rating and announces Price Target of $40.
benzinga.com Wedbush Initiates Coverage On Aktis Oncology with Outperform Rating, Announces Price Target of $35 Wedbush analyst David Nierengarten initiates coverage on Aktis Oncology (NASDAQ:AKTS) with a Outperform rating and announces Price Target of $35.
benzinga.com BMO Capital Initiates Coverage On Aktis Oncology with Outperform Rating, Announces Price Target of $37 BMO Capital analyst David Lebowitz initiates coverage on Aktis Oncology (NASDAQ:AKTS) with a Outperform rating and announces Price Target of $37.
benzinga.com Micron and 15 Other Stocks To Play The AI Buildout Race: They Are Still 20% Below Highs Bank of America screened its AI baskets for Buy-rated stocks down over 20% from highs. Micron carries the widest gap to target.
benzinga.com Aktis Oncology Q2 EPS $(0.44) Misses $(0.43) Estimate, Sales $3.384M Beat $2.000M Estimate Aktis Oncology (NASDAQ:AKTS) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 98.03 percent increase over losses of…- benzinga.com JP Morgan Maintains Overweight on Aktis Oncology, Raises Price Target to $33 JP Morgan analyst Jessica Fye maintains Aktis Oncology (NASDAQ:AKTS) with a Overweight and raises the price target from $30 to $33.
benzinga.com DigitalOcean, Agios Pharmaceuticals, Kingsoft Cloud And Other Big Stocks Moving Higher On Tuesday US stocks were mixed, Nasdaq fell 1%. DigitalOcean shares rose after strong revenue growth and earnings guidance. Other big gainers include CRNX, MAAS, and AGIO.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-market session. Crinetics Pharmaceuticals (NASDAQ:CRNX) stock moved upwards by 99.85% to $84.0. The…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's regular session. The market value of their outstanding shares is at $4.8 million. Seer (NASDAQ:SEER)…
benzinga.com This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday Top Wall Street analysts changed outlook on top names. For all changes, including upgrades/downgrades, visit analyst ratings page. Consider buying AKTS stock? Analysts weigh in.- benzinga.com Raymond James Initiates Coverage On Aktis Oncology with Strong Buy Rating, Announces Price Target of $40 Raymond James analyst Christopher Raymond initiates coverage on Aktis Oncology (NASDAQ:AKTS) with a Strong Buy rating and announces Price Target of $40.
benzinga.com Rezolve AI, Bakkt, Seagate And Other Big Stocks Moving Higher On Friday U.S. stocks were mixed, with the Dow Jones gaining 100 points. Rezolve AI (RZLV) jumped 11.9%, and other stocks such as ALOY and FWRD also rose.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com HC Wainwright & Co. Maintains Buy on Aktis Oncology, Raises Price Target to $35 HC Wainwright & Co. analyst Robert Burns maintains Aktis Oncology (NASDAQ:AKTS) with a Buy and raises the price target from $33 to $35.
- benzinga.com Aktis Oncology's AKY-2519 Shows Robust Tumor Uptake And Favorable Dosimetry Across Solid Tumors In First-In-Human B7-H3 Radiopharmaceutical Data Presented At ASCO 2026 Data to be presented across two posters at the 2026 American Society of Clinical Oncology (ASCO) Annual MeetingCombined results evaluating AKY-2519 across several B7-H3 expressing tumor types,…
- benzinga.com Aktis Oncology Q1 EPS $(0.38) Beats $(0.44) Estimate, Sales $3.227M Beat $1.750M Estimate Aktis Oncology (NASDAQ:AKTS) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.44) by 13.64 percent. This is a 97.96 percent increase over losses of…
benzinga.com Aktis Oncology Starts Phase 1b Clinical Study Of AKY-25191 In Participants With Metastatic Castration-resistant Prostate Cancer Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations,…
benzinga.com This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform ratings and price targets. See other analysts' views.- benzinga.com William Blair Initiates Coverage On Aktis Oncology with Outperform Rating William Blair analyst Alexandra Ramsey initiates coverage on Aktis Oncology (NASDAQ:AKTS) with a Outperform rating.
- benzinga.com TAktis Oncology To Present First Clinical Imaging And Dosimetry Data For AKY-2519 At the 2026 American Society of Clinical Oncology Annual Meeting Aktis Oncology, Inc. (NASDAQ:AKTS) (the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including…
benzinga.com This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Top analysts change outlook on top names. See all analyst rating changes on Benzinga's analyst ratings page. Consider AKTS stock based on analyst views.
benzinga.com This GCI Liberty Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - benzinga.com Crude Oil Down 1%; Webuy Global Shares Spike Higher
- benzinga.com Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
benzinga.com 12 Information Technology Stocks Moving In Thursday's Pre-Market Session - benzinga.com 12 Information Technology Stocks Moving In Friday's After-Market Session
benzinga.com 12 Information Technology Stocks Moving In Wednesday's Pre-Market Session - benzinga.com Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
benzinga.com 12 Information Technology Stocks Moving In Tuesday's Intraday Session - benzinga.com Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
- benzinga.com Nasdaq Surges Over 100 Points; Nvidia Posts Upbeat Q1 Results
- benzinga.com Why NVIDIA Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
- benzinga.com Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
benzinga.com Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Information Technology Stocks Moving In Monday's After-Market Session
- benzinga.com Dow Falls Over 150 Points; Sohu Posts Q1 Loss
- benzinga.com Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- benzinga.com US Stocks Mixed; Li Auto Shares Plummet After Q1 Results
- benzinga.com Gold Down Over 1%; AC Immune Shares Spike Higher
- benzinga.com Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- benzinga.com 12 Information Technology Stocks Moving In Monday's Intraday Session
- benzinga.com Crude Oil Surges Over 1%; Amprius Technologies Shares Plunge
- benzinga.com 12 Information Technology Stocks Moving In Wednesday's After-Market Session
- benzinga.com Earnings Scheduled For February 13, 2024 Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
- benzinga.com Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the…
- benzinga.com 12 Information Technology Stocks Moving In Thursday's Intraday Session
- benzinga.com Earnings Scheduled For November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 225 companies set new 52-week lows.